Glycemic impact of intensified self monitoring of blood glucose in insulin treated subjects with type 2 diabetes mellitus

Objective:The aim of this study was to evaluate if intensified self-monitoring of blood glucose (SMBG) improves glycemic control in insulin-treated subjects with type 2 diabetes mellitus (T2DM).

Methods:Ninety-six adults with stable but poorly controlled [glycated hemoglobin (HbA1c) level >7.5%] T2DM receiving twice-daily biphasic insulin were randomly assigned to either of the two groups: intensive monitors (IM) that performed SMBG at least twice daily or conventional monitors (CM) that performed SMBG at their discretionary frequency for 12 weeks. Demographic, clinical, and glycemic indices, including fasting blood glucose (FBG), postprandial glucose (PPG), and HbA1c, were compared at baseline and week 12.

Results:A total of 71 subjects (25 IM and 46 CM) completed the study. Both groups had similar HbA1c at baseline. From baseline to week 12, the IM group had higher mean daily test strip usage (P <0.001), engaged in more frequent insulin dose adjustments (P <0.001), and attained greater daily insulin dosage (P = 0.002). All glycemic indices including FBG, PPG, and HbA1c improved significantly from baseline to week 12 in the IM but not in the CM group. HbA1c level declined by −1.2 ±0.4% in the IM group (P = 0.002). There was no difference in the frequency of hypoglycemia in both groups. The monthly cost of intensified SMBG was nearly four times that of conventional monitoring (P <0.001).

Conclusion:Both short- and long-term glycemic control significantly improved by intensified SMBG in stable but poorly controlled insulin-treated adults with T2DM. Intensified SMBG enabled better self-titration of insulin and probably other self-care practices. This benefit, however, occurred at the expense of costs that may be difficult to sustain in resource-poor countries.

Keywords

Blood glucose - insulin - Nigeria - self-monitoring - type 2 diabetes mellitus

• References

• 1 IDF Clinical Guidelines Task Force: Global Guideline for Type 2 Diabetes 2012 Available from: www.idf.org/sites/default/files/IDF%20T2DM%20Guideline.pdf [Last accessed on 2016 Oct 15].
• 2 American Diabetes Association. Glycaemic targets. Sec. 5. In: Standards of Medical Care in Diabetes 2016 Diabetes Care 2016; 9 (Suppl. 01) S39-S46
• 3 Diabetes Control and Complications Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
• 4 UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853
• 5 Miller KM, Beck RW, Bergenstal RM, Goland RS, Haller MJ, McGill JB. et al. Evidence of a strong association between frequency of self monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants.. Diabetes Care 2013; 36: 2009-2014
• 6 Clar C, Barnard K, Cummins E, Royle P, Waugh N. Aberdeen Health Technology Assessment Group. Self-monitoring of blood glucose in type 2 diabetes: Systematic review. Health Technol Assess 2010; 14: 1-140
• 7 Davis WA, Bruce DG, Davis TM. Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes Study. Diabetologia 2007; 50: 510-515
• 8 Guerci B, Drouin P, Grange V, Bougneres P, Fontaine P, Kerlan V. et al. The ASIA Group. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: The Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003; 29: 587-594
• 9 Soumerai SB, Mah C, Zhang F, Adams A, Barton M, Fajtova V. et al. Effects of health maintenance organization coverage of self-monitoring devices on diabetes self-care and glycaemic control. Arch Intern Med 2004; 164: 645-652
• 10 Chinenye S, Ofoegbu EN, Onyemelukwe GC, Uloko AE, Ogbera AO. In: Clinical Practice Guidelines for Diabetes Management in Nigeria. 2nd ed. Diabetes Association of Nigeria 2013; 12-13
• 11 World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of WHO Consultation WHO/NCD/NCS/99. Geneva: WHO 1999; 1-58
• 12 National Prescribing Centre. Data focused commentary: Type 2 diabetes: Self monitoring of blood glucose. 2012 Available from: http://www.npc.nhs.uk/therapeutics/cardio/diabetes_2/resources/dfc_self_monitoring_of_blood_glucose.pdf [Last accessed on 2017 Jan 5].
• 13 Ugwu ET, Orjioke CJG, Young EE. Self monitoring of blood glucose among patients with type 2 diabetes mellitus in eastern Nigeria: Need for multi-strategic interventions. Curr Diabetes Rev 2016 Oct 14. DOI: 10.2174/1573399812666161014111618. [Epub ahead of print].
• 14 Murata C, Shah JH, Hoffman RM, Wendel CS, Adam KD, Solvas PA. et al. Intensified blood glucose monitoring improves glycaemic control in stable, insulin-treated veterans with type 2 diabetes: The Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care 2003; 26: 1759-1763
• 15 Karter AJ, Ackerson LM, Darbinian JA, D'Agostino Jr RB, Ferrara A, Liu J. et la. Self-monitoring of blood glucose levels and glycaemic control: The Northern California Kaiser Permanente Diabetes Registry. Am J Med 2001; 111: 1-9
• 16 Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S. et la. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-117
• 17 Neeser K, Weber C. Cost impact of self measurement of blood glucose on complications of type 2 diabetes: The Spanish perspective. Diabetes Technol Ther 2009; 11: 509-516
• 18 Yeaw J, Lee WC, Wolden ML, Christensen T, Groleau D. Cost of self-monitoring of blood glucose in Canada among patients on an insulin regimen for diabetes. Diabetes Ther 2012; 3: 7
• 19 Gallichan M. Self monitoring of glucose by people with diabetes: Evidence based practice. BMJ 1997; 314: 964-967
• 20 Harris MI. Frequency of blood glucose monitoring in relation to glycaemic control in patients with type 2 diabetes. Diabetes Care 2001; 24: 979-982
• 21 Peel E, Parry O, Douglas M, Lawton J. Blood glucose self monitoring in non-insulin-treated type 2 diabetes: A qualitative study of patients' perspectives. Br J Gen Pract 2004; 54: 183-188
• 22 Avignon A, Radauceanu A, Monnier L. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 1997; 20: 1822-1826
• 23 Soonthornpun S, Rattarasarn C, Leelawattana R, Setasuban W. Postprandial plasma glucose: A good index of glycaemic control in type 2 diabetic patients having near-normal fasting glucose levels. Diabetes Res Clin Pract 1999; 46: 23-27
• 24 Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A. et la. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: Open parallel group randomised trial. BMJ 2007; 335: 132
• 25 O'Kane MJ, Bunting B, Copeland M, Coates VE. On behalf of the ESMON study group. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): Randomized controlled trial. BMJ 2008; 336: 1174-1177
• 26 Central Intelligence Agency (US) report 2010. Available from: https://www.cia.gov/library/publications/the-world-factbook/fields/2046.html [Last accessed on 2017 Jan 8].